Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging by Oppelt, Peter et al.
Human Reproduction Vol.21, No.3 pp. 792–797, 2006 doi:10.1093/humrep/dei381
Advance Access publication November 10, 2005.
792 © The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournals.org 
Clinical aspects of Mayer–Rokitansky–Kuester–Hauser 
syndrome: recommendations for clinical diagnosis 
and staging
Peter Oppelt1,5, Stefan P.Renner1, Anja Kellermann1, Sara Brucker2, Georges A.Hauser3, 
Kurt S.Ludwig4, Pamela L.Strissel1, Reiner Strick1, Diethelm Wallwiener2 and 
Matthias W.Beckmann1
1Department of Gynecology and Obstetrics, University Hospital, Universitätsstrasse 21–23, D-91054 Erlangen, 2Department of Gynecology 
and Obstetrics, University Tübingen, Calwerstraße 7, 72076 Tübingen, Germany, 3Swiss Medical Association (FMH), Allenwindenstrasse 7, 
CH-6004 Lucerne and 4Department of Anatomy, University of Basel, Pestalozzistrasse 20, CH-4056 Basel, Switzerland
5To whom correspondence should be addressed. E-mail: Peter.Oppelt@gyn.imed.uni-erlangen.de
BACKGROUND: The Mayer–Rokitansky–Kuester–Hauser (MRKH) syndrome is a malformation of the female genitals
(occurring in one in 4000 female live births) as a result of interrupted embryonic development of the Müllerian (par-
amesonephric) ducts. This retrospective study examined the issue of associated malformations, subtyping, and the
frequency distribution of subtypes in MRKH syndrome. METHODS: Fifty-three MRKH patients were investigated
using a newly developed standardized questionnaire. Together with the results of clinical and diagnostic examinations,
the patients were classified into the three recognized subtypes [typical, atypical and MURCS (Müllerian duct aplasia,
renal aplasia, and cervicothoracic somite dysplasia)]. RESULTS: The typical form was diagnosed in 25 patients
(47%), the atypical form in 11 patients (21%), and the most marked form—the MURCS type—in 17 patients (32%).
Associated malformations were notably frequent among the patients. Malformations of the renal system were the
most frequent type of accompanying malformation, with 23 different malformations in 19 patients, followed by 18
different skeletal changes in 15 patients. CONCLUSIONS: In accordance with the literature, this study shows that
associated malformations are present in more than a third of cases. Therefore, new basic guidelines for standard
diagnostic classification involving patients with suspected MRKH are presented.
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Introduction
The Mayer–Rokitansky–Kuester–Hauser (MRKH) syndrome
is regarded as an inhibitory malformation of the Müllerian
(paramesonephric) ducts. Clinically, this malformation of the
female genital organs presents as a rudimentary solid bipartite
uterus with solid vagina (‘uterus bipartitus solidus rudimentar-
ius cum vagina solida’). Avicenna (AD 980–1037) and Albucasis
(AD 1013–1100), described successful correctional treatment
for vaginal aplasia. However, these reports cannot be clearly
connected with today’s MRKH syndrome, since exploration
of the internal genital organs did not take place during that
period. Exploration was first described by the Bonn anato-
mist and physiologist Mayer (1829). This was a report of a
single case, with the malformation only being inadequately
described as ‘uterus bipartitus’. Kussmaul (1859) and also
Rokitansky (1938) also reported the same diagnosis of mal-
formation in one case each. Kuester (1910) for the first time
summarized and collected individual cases from the litera-
ture in a review paper. It was only in 1961 that the ‘rudimentary
solid septate uterus with solid vagina’ was first given its
current name, ‘Mayer–Rokitansky–Kuester syndrome’ by
the gynaecologist Hauser (Hauser and Schreiner, 1961),
later being extended to ‘Mayer–Rokitansky–Kuester–Hauser’
syndrome.
The MRKH syndrome develops in utero between the fourth
and twelfth week of pregnancy. Griffin et al. (1976) reported
familial clustering. The molecular basis for the condition has
not yet been fully explained. Activation of Müllerian inhibiting
substance (MIS) or anti-Müllerian hormone might offer one
possible explanation, leading to regression of the Müllerian
ducts and thus to vaginal atresia or uterine agenesis. A recent
molecular investigation did not identify any deletions or poly-
morphisms in the promoter region, and measurements of MIS
in affected patients did not demonstrate any increased serum
concentrations, and overexpression of MIS was therefore not
present (Oppelt et al., 2004). The molecular basis for the
MRKH syndrome is currently unknown. In addition, no other
gene variation in MIS, MIS-Receptor (MISR2) and Wilm’s
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tumours were found (Van Lingen et al., 1998; Resendes et al.,
2001; Zenteno et al., 2004).
MRKH patients have normal development of the female
phenotype, with normal thelarche and pubarche, and a female
karyotype (46,XX) with primary amenorrhoea. The clinical
picture shows a septate, rudimentary uterus, aplasia of the cervix
and vagina, and normal or hypoplastic bilateral adnexa. Brown
(1959) and Fraser et al. (1973) have shown both that ovarian
function is intact, as evident in correctly timed pubarche and
thelarche and the presence of a biphasic basal temperature
curve, and also that hormonal secretion does not differ from
that in normal individuals.
The extent of MRKH syndrome is variable, and it is associ-
ated with various additional malformations. This is reflected in
the classification, which is subdivided into typical and atypical
depending on each additional malformation that is present
(Table I). When additional associated malformations of the
renal system and skeleton are present, Duncan et al. (1979)
proposed the term MURCS (Müllerian duct aplasia, renal aplasia,
and cervicothoracic somite dysplasia). In order to verify hints
of specific associated malformations with MRKH, this study
analysed all symptoms of 53 patients.
Materials and methods
Between January 2002 and September 2004, 53 MRKH patients from
Austria, Switzerland, and Germany were included in the study.
The patients presented either to the Department of Gynecology at the
University of Erlangen, in contact with the Erlangen MRKH Forum
website (www.mrkh-syndrom.de), or were identified in collaboration
with the following hospitals: the Department of Gynecology at the
University of Tübingen; the Department of Gynecology at the Univer-
sity of Hamburg at Eppendorf; and the Department of Gynecology at
the Bürgerhospital, Frankfurt am Main.
All patients received the questionnaire and there were no non-
responders. The patients were questioned using a newly developed
standardized questionnaire (including 77 questions) with regard to
general details, personal data, and symptoms. The syndrome was con-
firmed and classified using surgical reports and letters from the patients’
physicians. The patients were classified using the Schmid-Tannwald
classification (Schmid-Tannwald and Hauser, 1977) and/or the Duncan
classification (Duncan et al., 1979) (typical, atypical, MURCS).
A diagnosis of MRKH syndrome was made with laparoscopy in
53 women included in the study. At the time of data collection, the
youngest of the patients was aged 13 and the oldest was 53 (median
26 years). Approval for the study was obtained from the ethics com-
mittee at the University of Erlangen (ethics vote no. 3074).
Results
In the group of 53 patients, 25 women (47%) had the typical
form of MRKH syndrome, 11 women (21%) had the atypical
form, and 17 patients (32%) had the marked form known as
MURCS (Table II).
The rudimentary uterus was present as a horn or bud in sym-
metrical form in 39 women (74%); in two patients (4%), it was
formed asymmetrically, with the agenesis located on the right
side in one case and on the left in the other. Bilateral agenesis
was diagnosed in 12 patients (23%). Unilateral agenesis of the
tubes was seen in three patients (6%), and bilateral agenesis in
only one patient. One woman had unilateral agenesis of the
ovary, and two had bilateral gonadal streaks. Other benign
changes observed included unilateral ovarian fibroma in one
case and a myoma in the uterine horn in another patient.
The group of patients included 19 women with MRKH
(36%) who also had anomalies in the renal system. These
included 12 cases of unilateral agenesis (five left-sided, seven
right-sided; 23%), nine cases of unilateral pelvic kidney (one
left-sided, eight right-sided; 17%), and two left-sided sclerotic
kidneys (4%).
Fifteen patients were suffering from skeletal malformations
in the wider sense (28%). The most frequent changes involved
the spine. Six patients with these conditions had scoliosis
(11%), and vertebral arch disturbances at C4–5 were diag-
nosed in one patient. In one case spinal malformations were
also reported, each in association with Scheuermann’s disease
and Klippel–Feil syndrome. One patient had radial aplasia–
thrombocytopenia syndrome with bilateral club hand, and two
had hypoplasia of the wrist. Hip deformities were observed in
four patients. Other skeletal malformations noted in the group
were: one deformed elbow, an absence of one-third of the
lower arm, a jaw anomaly, absence of wisdom teeth, and one
case of talipes varus. When all of the skeletal malformations
are taken together, it is notable that the extremities were affected
in 47% of the cases.
Isolated malformations were observed in the study in the
form of three cases of ventricular septal foramen and two of
unilateral hearing impairment. There were also seven cases of
inguinal hernia. Other changes noted included one naevocytic
naevus, one case of hypothyroidism, one of high blood pres-
sure, and one cataract.
Forty of the women underwent vaginal reconstruction surgery,
two decided in favour of Frank’s dilation method, and 14 women
in the group have not yet received a neovagina to date.
Discussion
Various malformations associated with MRKH syndrome have
been described in the literature. They originate in the interac-
tion between the Wolffian and Müllerian ducts during the first
few weeks of embryonic growth. The most frequent associated
malformations reported are changes in the area of the urogenital
tract. Nation (1944) drew attention to disturbances of the uro-
genital tract in connection with genital malformations. Unilat-
eral renal aplasia was present in 44% of the cases he reported.
In 1957, in a study reporting experience in vaginal reconstruc-
tions, Barrows (1957) also reported on ectopic locations of the
Table I. Classification of the Mayer–Rokitansky–Kuester–Hauser (MRKH) 
syndrome according to Schmid-Tannwald and Hauser (1977) and Duncan 
et al. (1979)
MURCS = Müllerian aplasia, renal aplasia, and cervicothoracic somite dysplasia 
(association).
MRKH syndrome Associated malformations
Typical Tubes, ovaries, and renal system generated and developed
Atypical Malformations in the ovary or renal system
MURCS Malformations in the skeleton and/or heart; muscular 
weakness, renal malformations
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Table II. Classification and associated malformations in Mayer–Rokitansky–Kuester–Hauser (MRKH) patients
MURCS = Müllerian aplasia, renal aplasia, and cervicothoracic somite dysplasia (association).
aAtresia.
bHypoplastic horn.
cAgenesis.
dPelvic kidney.
eNephrosclerosis.
ND = not described.
Patient no. 
(lab. no.)
Vagina Uterus Ovary Tube Kidney Skeleton Inguinal hernia Heart Classification Associated malformations
Left Right Left Right Left Right Left Right
1. (205) a b b Typical
2. (288) a b b Typical
3. (376) a c c Typical
4. (384) a b b Typical
5. (752) a b b Typical
6. (1104) a b b ND ND ND ND ND ND ND Typical Myoma
7. (1138) a b b Typical
8. (1193) a b b Typical
9. (1231) a c c Typical
10. (1337) a b b ND ND ND ND Typical
11. (1740) a b b Typical
12. (1899) a b b ND ND ND ND Typical
13. (2454) a c c Typical
14. (2585) a b b ND ND ND Typical
15. (2703) a b b Typical
16. (2899) a b b ND ND ND ND Typical
17. (3116) a b b Typical
18. (3147) a b b Typical
19. (3231) a b b Yes Typical Naevocytic naevus
20. (3294) a b b Typical
21. (3350) a b b Typical
22. (3434) a b b Typical
23. (3477) a b b Typical
24. (3478) a c c Typical
25. (3481) a c c Typical
26. (331) a b b c c ATypical
27. (368) a c c c ATypical
28. (1239) a c c c c ATypical
29. (1617) a c c d ATypical
30. (2179) a b b e ATypical
31. (2285) a b b ATypical
32. (2885) a b b ND ND ND ND c ATypical Hypothyroidism
33. (2910) a b b ND ND ND ND c ATypical
34. (3258) a b b d d ND ATypical Merged
35. (3394) a c c ND ND c Yes ATypical
36. (3417) a c c c d Yes ATypical Dwarfism, fibroma
37. (390) a b b ND ND Yes MURCS Scoliosis
38. (448) a b b c Yes Yes MURCS Corticopulmonary septal defect
39. (751) a c b c c c d Yes MURCS Scoliosis
40. (1832) a c c Streak Streak c Yes MURCS
41. (1891) a b b e Yes MURCS Scheuermann’s disease, 
scoliosis
42. (2097) a b b ND ND ND ND d c MURCS Aorticopulmonary septal defect
43. (1094) a b b ND ND ND ND d Yes MURCS Talipes varus, congenital 
dysplasia of the hip
44. (1232) a b b ND ND ND ND Yes MURCS Hearing problems, hypoplasia 
of the wrist
45. (1402) a b b c c d Yes c MURCS Open duct and jaw anomaly
46. (1504) a b b ND ND ND ND Yes MURCS Absence of 1/3 of the left arm
47. (1664) a b b c d Yes Yes MURCS High blood pressure, 
hypoplasia of the wrist, 
Scoliosis
48. (1665) a c b Streak Streak c Yes MURCS Deformed elbow, scoliosis, 
congenital dysplasia of the hip
49. (2599) a c c Yes MURCS Radial aplasia–
thrombocytopenia syndrome 
with bilateral club hand, 
Congenital dysplasia of the hip
50. (2969) a b b Yes Yes MURCS Vertebral arch disturbances at 
C4/5, inner ear hearing loss
51. (3021) a b b Yes MURCS Cataract, scoliosis
52. (3103) a b b Yes c MURCS Aorticopulmonary septal defect
53. (3521) a b b c c Yes MURCS Klippel–Feil syndrome
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kidney such as pelvic kidney, horseshoe kidney, and double
ureter. Hauser and Schreiner (1961) described renal aplasia and
duplication of the renal pelvis in MRKH syndrome. Griffin
(1976) added descriptions of functional disturbances, malrota-
tions, and solitary kidneys. The renal system is the organ group
that shows associated changes most frequently, with 23 different
malformations of the renal system in 19 patients (36%) in the
present study. This demonstrates the need for diagnostic clari-
fication of the renal system at the first diagnosis of MRKH
syndrome (Table III).
Changes in the ovary and tubes can vary in their severity.
For example, Gradenwitz (1903), Glimm (1956), and Hauser
and Schreiner (1961) reported a tendency toward polycystic
degeneration of the ovaries. Rokitansky (1838) and Bompiani
and Rigat (1958) described hypoplastic ovaries. In the present
study, the group included two patients with bilateral gonadal
streaks and one with unilateral ovarian aplasia. Particularly in
connection with disturbance of the ovarian primordium, a
reduced estrogen level can occur, with effects on the develop-
ment of secondary sexual characteristics and bone metabolism;
age-related hormone measurements are therefore a useful and
advisable component of the diagnostic work-up.
As the fundamental embryonic structure involved in the
process, the mesoderm establishes the connection between the
differentiation of the uterus from the Wolffian and Müllerian
ducts, with the development of the urogenital system, and the
skeletal system. As was also observed in the present study,
Griffin et al. (1976) thus noted an increased frequency of skel-
etal anomalies in addition to renal malformations.
The skeletal malformations observed include spina bifida,
sacralization of L5, lumbarization of the sacral bone (S1), and
malformations of the cervical vertebrae. This leads to difficulty
in distinguishing between Klippel–Feil syndrome (Strubbe
et al., 1992) (with the formation of block vertebrae in the cer-
vical region) and MURCS. Since a triggering genetic factor
has not yet been described in either case, and both are purely
descriptive classifications, these may represent one and the
same syndrome in some patterns. Similarly, anomalies of the
extremities, particularly in the hands and fingers (syndactyly),
rib deformities, cleft palate, shoulder blade and pelvic deformities,
as well as vertebral abnormalities, particularly in the cervical
and thoracic vertebrae, have also been reported.
Cardiac malformations and neurological disturbances appear
to play a minor role (Hauser and Schreiner, 1961; Leduc et al.,
1968; Reindollar et al., 1981). For example, three patients in
the present study had ventricular septal defects, and two had
unilateral hearing problems. It is notable that in both of the latter
cases, no other unilateral associated malformations were
described (Table II).
Other individually occurring malformations reported have
included cheilognathouranoschisis, bowel rotation, and situs
inversus (Hauser and Schreiner, 1961; Leduc et al., 1968).
However, none of these was observed in the group described
here.
The present analysis shows that 53% of the patients were
affected by secondary malformations. Malformations may be
present (e.g. the teeth) that are at first sight unconnected with
the MRKH syndrome. Since no genetic causality has yet been
identified with regard to the malformation, it is difficult to con-
firm any connection between the typical genital malformation
and accompanying changes (Oppelt et al., 2004). However, the
clinical findings are conspicuous, with associated malforma-
tions being reported in the literature in up to 64% of patients
with MRKH syndrome (Griffin et al., 1976). For this reason, it
is important that patients with MRKH syndrome should be
regarded as having not only a genital malformation syndrome,
but rather as having a complex syndrome with possible accom-
panying malformations in other organ groups.
When the associated malformations in a further 16 MRKH
groups described in the published literature are added together,
the syndrome is seen to be limited to vaginal aplasia and uter-
ine hypoplasia or aplasia in only 64% of the cases (333 of 521
patients; Table IV), representing the typical case of MRKH. In
this overall group, the high proportion of associated malforma-
tions is again evident, with changes in the renal system repre-
senting the largest proportion of the organs affected, in 32% of
the patients (n = 166).
Since it is not sensible to conduct a search for every possible
malformation, a primary basic diagnostic clarification with
additional symptom-oriented diagnoses may be recommended.
Table IIIa attempts to provide an overview of essential and
supplementary examinations. Magnetic resonance imaging is
considered an essential diagnostic tool but laparoscopy is still a
recommended analysis to diagnose MRKH. For guidance,
Table IIIb lists all of the points that should be discussed with
patients in the context of basic diagnostic clarification. An
exact documentation, with photographic and/or video docu-
mentation during laparoscopy, will contribute greatly to the
understanding of each MRKH case.
Since MRKH syndrome is purely a diagnosis of exclusion,
chromosome analysis is essential to differentiate it from other
malformations, such as testicular feminization. Assessment
of sex hormones must be regarded as a component of the
basic diagnostic clarification, since estrogen production can be
Table IIIa. New basic examinations for diagnostic clarification of 
Mayer–Rokitansky–Küster–Hauser syndrome
MRI: magnetic resonance imaging.
Essential examinations
Chromosome analysis
MRI of the kidneys and small pelvis
Hormone status (LH, FSH, estradiol)
Recommended additional examinations
Ultrasound of the vaginal vestibule, rectum
Diagnostic laparoscopy
Ovarian biopsy
Table IIIb. Principal symptoms for supplementary examinations to clarify 
associated malformations
Symptoms Diagnostic clarification
Urinary incontinence Urodynamics
Quick exhaustion Myography, echocardiography
Skeletal malformations Radiography, computed tomography if appropriate
Hearing loss Audiography
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completely absent in non-functional ovaries, with a consequent
negative effect on bone metabolism. In addition, a differential
diagnosis from the adrenogenital syndrome (Bryan et al., 1988)
should also be performed (e.g. with chromosomal analyses).
Ovarian biopsy is recommended because of the possibility
of detecting ‘streak gonads’ in MRKH patients.
In conclusion, it should be pointed out once again that
MRKH syndrome must not be regarded as being exclusively a
genital malformation, and that associated malformations are
frequently present. Due to their frequency, it is absolutely
necessary to clarify these as well during the differential diag-
nosis of malformations.
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